Related Experiment Video
Updated: Jun 18, 2026

Heuristic Mining of Hierarchical Genotypes and Accessory Genome Loci in Bacterial Populations
Published on: December 7, 2021
Genetic commonality of macrolide-resistant group A beta hemolytic streptococcus pharyngeal strains
Angela L Myers1, Mary Anne Jackson, Rangaraj Selvarangan
1Children's Mercy Hospitals and Clinics, University of Missouri-Kansas City School of Medicine, KC, MO, USA. amyers@cmh.edu
Insights
Macrolide resistance in Group A beta-hemolytic streptococcus (GABHS) pharyngitis has increased in children. This rise in erythromycin resistance may impact treatment choices for penicillin-allergic patients.
Area of Science:
- Pediatric infectious diseases
- Microbiology
- Antimicrobial resistance
Background:
- Group A beta-hemolytic streptococcus (GABHS) pharyngitis is a frequent childhood illness.
- Penicillin is the primary treatment, while macrolides are alternatives for allergic individuals.
- Increased macrolide use may correlate with rising resistance rates.
Purpose of the Study:
- To assess current erythromycin resistance levels in GABHS pharyngitis isolates.
- To compare resistance data with previous findings from 2002.
- To investigate the genetic relatedness of resistant isolates.
Main Methods:
- A surveillance study of children with pharyngitis and positive rapid antigen testing was conducted.
- Erythromycin resistance was determined using disk diffusion and E-test on 500 isolates.
- Pulse field gel electrophoresis (PFGE) analyzed the genetic relatedness of isolates.
Main Results:
- Erythromycin resistance was 3.5% at site A and 4.5% at site B in 2005-06, compared to 0% in 2002.
- Inducible resistance was observed in a subset of isolates.
- PFGE revealed genetic relatedness among some resistant isolates.
Conclusions:
- Community macrolide resistance has increased, likely due to elevated macrolide consumption.
- The rising resistance may necessitate re-evaluation of treatment guidelines for GABHS pharyngitis.
Background:
Group A beta hemolytic streptococcus (GABHS) pharyngitis is a common childhood illness. Penicillin remains the gold standard therapy, but macrolides are indicated for the penicillin allergic patient, and are often used for convenience.
Methods:
We conducted a surveillance study of children with pharyngitis and positive streptococcal rapid antigen testing from 10/05 to 10/06 at 2 sites (A & B). Demographics, treatment, and resistance data was collected and compared to previous data from 2002. Erythromycin (EM) resistance was determined by disk diffusion and E-test on 500 isolates. Pulse field gel electrophoresis (PFGE) was performed to measure genetic relatedness of isolates. StatXact version 8 software (Cytel Inc., Cambridge, MA) was utilized to perform Fisher's exact test and exact confidence interval (CI) analysis.
Results:
There were no differences in resistance rates or demographic features, with the exception of race, between sites A & B. EM resistance was 0 in 2002, 3.5% in 2005-06 at site A, and 4.5% in 2005-06 at site B. 3/7 and 3/9 had inducible resistance at A and B respectively. 8 isolates had relatedness > or =80%, 5 of which were 88% homologous on PFGE.
Conclusion:
Community macrolide resistance has increased following increased macrolide use. These results may have treatment implications if use continues to be high.
Related Concept Videos
Streptococcal Pharyngitis
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Atypical Pneumonia
Development of Antibiotic Resistance
Bacterial Phylum Actinobacteria